ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,567.30
-0.98%
S&P ASX All Technology
2,930.40
-1.06%
Brent Oil
86.625
0.00%
US Dollar vs AUD
1.5586
0.00%
Bitcoin
63,973.00
0.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Apellis Pharmaceuticals Inc (APLS)

  7. Apellis Pharmaceuticals Inc (APLS) News

APLS Apellis Pharmaceuticals Inc

47.53
0.02 (0.04%)
20 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Apellis Pharmaceuticals Inc APLS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.02 0.04% 47.53 07:30:00
Open Price Low Price High Price Close Price Previous Close
47.52 46.53 48.19 47.53 47.51
more quote information »

Recent News

Date Time Source Heading
05/4/202407:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
01/4/202422:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the 23rd..
12/3/202407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202422:00GLOBEApellis Appoints Leading Expert Dr. Philip Ferrone as Chief..
09/3/202408:10EDGAR2Form 144 - Report of proposed sale of securities
08/3/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
06/3/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202408:25EDGAR2Form 144 - Report of proposed sale of securities
02/3/202405:37EDGAR2Form 144 - Report of proposed sale of securities
01/3/202409:10EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27/2/202423:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202423:30EDGAR2Form 8-K - Current report
27/2/202423:05GLOBEApellis Pharmaceuticals Reports Fourth Quarter and Full Year..
27/2/202423:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202423:00GLOBEApellis Pharmaceuticals to Present at Upcoming Investor..
20/2/202423:00GLOBEApellis Pharmaceuticals to Host Conference Call on February..
15/2/202409:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/2/202401:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202409:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202409:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202407:46EDGAR2Form 144 - Report of proposed sale of securities
13/2/202407:43EDGAR2Form 144 - Report of proposed sale of securities
13/2/202407:28EDGAR2Form 144 - Report of proposed sale of securities
13/2/202407:27EDGAR2Form 144 - Report of proposed sale of securities
13/2/202407:22EDGAR2Form 144 - Report of proposed sale of securities
13/2/202407:19EDGAR2Form 144 - Report of proposed sale of securities
07/2/202408:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
01/2/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202402:50EDGAR2Form 144 - Report of proposed sale of securities
31/1/202402:04EDGAR2Form 144 - Report of proposed sale of securities
30/1/202407:22EDGAR2Form 144 - Report of proposed sale of securities
30/1/202407:21EDGAR2Form 144 - Report of proposed sale of securities
30/1/202407:21EDGAR2Form 144 - Report of proposed sale of securities
30/1/202407:19EDGAR2Form 144 - Report of proposed sale of securities
30/1/202407:17EDGAR2Form 144 - Report of proposed sale of securities
30/1/202407:16EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

NASDAQ
APLS
Apellis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved